Tae Won Kim
Full Name & Degree
Tae Won Kim M.D., Ph.D.
Office Address
Department of Oncology, Clinical Pharmacology and Therapeutics,
Asan Medical Center (AMC), University of Ulsan
88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea
Specialty
Colon Cancer
Major Professional Experiences
- Korean Cancer Association Vice-president
- Clinical Colorectal Cancer Editor in chief
- Korean Sociery of Medical Oncology Chairman
- Korean Cancer Foundation Chairman of the board
- Professor in Oncology, UUCM AMC
Publications
Original Articles
[SCI/SCIE Journals]
- Jo S, Oh JH, Lee EJ, Choi M, Lee J, Lee S, Kim TW, Sung CO, Chung SJ. Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson's Disease. Mov Disord. 2025 Mar;40(3):502-510. PMID: 39760477
-
André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Alcaide-Garcia J, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Le DT, Yoshino T, Zuo Y, Fogelman D, Adelberg D, Diaz LA. Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study. Ann Oncol. 2025 Mar;36(3):277-284. PMID: 39631622
-
Jang YJ, Yang YJ, Koo HJ, Yoon HW, Uhm S, Kim SY, Kim JE, Huh JW, Kim TW, Seo S. Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea. Cancer Res Treat. 2025 Jan;57(1):280-288. PMID: 38965926
-
Kim BJ, Maeng CH, Keam B, Im YH, Ro J, Jung KH, Im SA, Kim TW, Lee JL, Heo DS, Kim SW, Park K, Ahn MJ, Cho BC, Kim HK, Kang YK, Cho JY, Yun HJ, Nam BH, Zang DY. The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group. Cancer Res Treat. 2025 Jan;57(1):39-46. PMID: 38993093
-
Ryu HS, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Hong YS, Kim TW, Yu CS. Effects of Adjuvant Chemotherapy on Oncologic Outcomes in Patients With Stage A Rectal Cancer Above the Peritoneal Reflection Who Did Not Undergo Preoperative Chemoradiotherapy. Clin Colorectal Cancer. 2024 Dec;23(4):392-401. PMID: 39033043
- Lee KW, Han SW, Kim TW, Ahn JB, Baek JY, Cho SH, Lee H, Kim JW, Kim JW, Kim TY, Hong YS, Beom SH, Cha Y, Choi Y, Kim S, Bang YJ. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer. Cancer Res Treat. 2024 Apr;56(2):590-601. PMID: 38062706
-
Desai J et al. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nat Med. 2024 Jan;30(1):271-278. PMID: 38052910
-
Shin Y, Moon BH, Ryoo BY, Chang HM, Kim KP, Hong YS, Kim TW, Ryu JS, Kim YI, Yoo C. Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea. Target Oncol. 2024 Jan;19(1):41-49. PMID: 38108953
